Drugs / gaxilose
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02636413 | Oct 2015 → Oct 2016 | lactose intolerance | VenterPharma | Completed | Met primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | gaxilose | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02636413 ↗ |
| Known as | Gaxilosa | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297512 ↗ |
| Modality | Diagnostic / imaging agent | “The diagnostic accuracy of the Gaxilose test (GT) for hypolactasia diagnosis has already been proved.” PMID 30431582 ↗ Nov 2018 |
| Route | Oral | “0,45 g of gaxilose po, once, per diagnostic test performed.” NCT02636413 ↗ |